Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Rogenhofer

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
MMW Fortschritte Der Medizin|February 27, 2021
[Hormonal Therapy - Curse or Blessing]Johanna Becker, Nina Rogenhofer
MMW Fortschritte Der Medizin|May 25, 2012
[Contra: opposing a simplistic hormone replacement therapy]Nina Rogenhofer, S Mittenzwei, K Friese, et al.
MMW Fortschritte Der Medizin|May 28, 2017
[The renaissance of hormonal therapy]Corinna Mann, Nina Rogenhofer, Sven Mahner, et al.
MMW Fortschritte Der Medizin|March 20, 2026
[Hormone replacement therapy in gynecologic cancers: Balancing safety and quality of life]Helena Bralo, Fabian Trillsch, Friederike Hagemann, et al.
Journal of Assisted Reproduction and Genetics|November 24, 2020
Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF)Nina Rogenhofer, Arseni Markoff, Xenia Ennerst, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 22, 2021
Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational reportNina Rogenhofer, Sven Mahner, Yumiko Lindgard von Hasselbach, et al.
Fertility and Sterility|May 26, 2012
Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot studyNina Rogenhofer, Laura Engels, Nadja Bogdanova, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 26, 2015
Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3Nina Rogenhofer, Viktoria von Schönfeldt, Robert Ochsenkühn, et al.
Journal of Reproductive Immunology|July 30, 2016
Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitroViktoria von Schönfeldt, Nina Rogenhofer, Katharina Ruf, et al.
Case Reports in Neurology|November 25, 2011
Uncomplicated pregnancy and delivery after previous severe postpartum cerebral angiopathyJan Rémi, Thomas Pfefferkorn, Gunther Fesl, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
MMW Fortschritte Der Medizin|February 27, 2021
[Hormonal Therapy - Curse or Blessing]Johanna Becker, Nina Rogenhofer
MMW Fortschritte Der Medizin|May 25, 2012
[Contra: opposing a simplistic hormone replacement therapy]Nina Rogenhofer, S Mittenzwei, K Friese, et al.
MMW Fortschritte Der Medizin|May 28, 2017
[The renaissance of hormonal therapy]Corinna Mann, Nina Rogenhofer, Sven Mahner, et al.
MMW Fortschritte Der Medizin|March 20, 2026
[Hormone replacement therapy in gynecologic cancers: Balancing safety and quality of life]Helena Bralo, Fabian Trillsch, Friederike Hagemann, et al.
Journal of Assisted Reproduction and Genetics|November 24, 2020
Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF)Nina Rogenhofer, Arseni Markoff, Xenia Ennerst, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 22, 2021
Effects of intralipid infusions on anti-trophoblast antibody (ATAb)-activities in patients with recurrent pregnancy loss: An observational reportNina Rogenhofer, Sven Mahner, Yumiko Lindgard von Hasselbach, et al.
Fertility and Sterility|May 26, 2012
Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot studyNina Rogenhofer, Laura Engels, Nadja Bogdanova, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|September 26, 2015
Effects of polyvalent immunoglobulins in patients with recurrent pregnancy loss and antibodies to the choriocarcinoma cell line JEG-3Nina Rogenhofer, Viktoria von Schönfeldt, Robert Ochsenkühn, et al.
Journal of Reproductive Immunology|July 30, 2016
Sera of patients with recurrent miscarriages containing anti-trophoblast antibodies (ATAB) reduce hCG and progesterone production in trophoblast cells in vitroViktoria von Schönfeldt, Nina Rogenhofer, Katharina Ruf, et al.
Case Reports in Neurology|November 25, 2011
Uncomplicated pregnancy and delivery after previous severe postpartum cerebral angiopathyJan Rémi, Thomas Pfefferkorn, Gunther Fesl, et al.
Pageof 6